Upstream Bio, Inc. — Income Charts
8 quarters of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Revenue, Gross Profit, Operating Income & Net Income
Margin (%)
Operating Expenses
Income Breakdown
Revenue↑+9.0% +$55K
$668K
R&D↑+84.5% +$18M
$40M
D&A↑+16.3% +$8K
$57K
Operating Income↓-100.3% -$19M
$-38M
EBITDA↑+16.3% +$8K
$57K
Interest Expense↑+94.1% +$5M
$10M
Interest Income↓-28.0% -$1M
$4M
Tax Provision
$0
Net Income↓-111.0% -$18M
$-34M
Operating Margin↓-2426.9pts
-5539.4%
Net Margin↓-2306.5pts
-4941.1%
ETR (Continuing Operations)↑+0.0pts
0.0%
ETR Federal Statutory↑+0.0pts
21.0%
ETR State + Local (pp)↑+0.0pts
0.0%
Revenue YoY Variation↓-27.2pts
9.0%
Income YoY Variation↑+1.0pts
-100.3%
Revenue QoQ Variation↓-3.2pts
-2.2%
Income QoQ Variation↑+22.4pts
14.7%